Merops Switch to
Peptidases

Inhibitor

Family Clan Small-molecule
inhibitor SEARCHES BLAST
MEROPS

Other
information

Literature for inhibitor I13.003: chymotrypsin inhibitor 2

Summary Alignment Sequences Sequence features Distribution Structure Literature

(Topics flags: S Structure, M Mutation. To select only the references relevant to a single topic, click the link above. See explanation.)

    2024
  1. Campos,L.A. and Munoz,V.
    Targeting the protein folding transition state by mutation: Large scale (un)folding rate accelerations without altering native stability
    Protein Sci33, e5031-e5031. PubMed  Europe PubMed DOI
    2. 2020
  2. B da Silva,F., M de Oliveira,V., Sanches,M.N., Contessoto,V.G. and Leite,V.B.P.
    Rational design of chymotrypsin inhibitor 2 by optimizing non-native interaction
    J Chem Inf Model60, 982-988. PubMed  Europe PubMed DOI
  3. Raab,S.A., El-Baba,T.J., Woodall,D.W., Liu,W., Liu,Y., Baird,Z., Hales,D.A., Laganowsky,A., Russell,D.H. and Clemmer,D.E.
    Evidence for Many Unique Solution Structures for Chymotrypsin Inhibitor 2: A Thermodynamic Perspective Derived from vT-ESI-IMS-MS Measurements
    J Am Chem Soc PubMed  Europe PubMed DOI
    4. 2019
  4. Wei,W., Chen,Y., Xie,D. and Zhou,Y.
    Molecular insight into chymotrypsin inhibitor 2 resisting proteolytic degradation
    Phys Chem Chem Phys21, 5049-5058. PubMed  Europe PubMed DOI
    5. 2016
  5. Mohanta,D. and Jana,M.
    Effect of ethanol concentrations on temperature driven structural changes of chymotrypsin inhibitor 2
    J Chem Phys144, 165101-165101. PubMed  Europe PubMed DOI
    6. 2011
  6. Whitley,M.J. and Lee,A.L.
    Exploring the role of structure and dynamics in the function of chymotrypsin inhibitor 2
    Proteins79, 916-924. PubMed  Europe PubMed DOI
    7. 2010
  7. Lindgren,M. and Westlund,P.O.
    The affect of urea on the kinetics of local unfolding processes in chymotrypsin inhibitor 2
    Biophys Chem151, 46-53. PubMed  Europe PubMed DOI
  8. Lindgren,M. and Westlund,P.O.
    On the stability of chymotrypsin inhibitor 2 in a 10 M urea solution. The role of interaction energies for urea-induced protein denaturation
    Phys Chem Chem Phys12, 9358-9366. PubMed  Europe PubMed DOI
  9. Liu,F.F., Ji,L. and Dong,X.Y.
    Effects of molecular volume and fractional polar surface area of osmolytes on the thermal stability of chymotrypsin inhibitor 2
    Acta Physico-Chim Sinica26, 2813-2820.
    10. 2009
  10. Zeng,X.H., Wei,Y.M., Jiang,Q.T., QI,P. and Zheng,Y.
    SNP analysis and haplotype identification in chymotrypsin inhibitor-2 (CI-2) gene of barley
    Agric Sci China8, 8-14. DOI  M
    11. 2008
  11. Whitley,M.J., Zhang,J. and Lee,A.L.
    Hydrophobic core mutations in CI2 globally perturb fast side-chain dynamics similarly without regard to position
    Biochemistry47, 8566-8576. PubMed  Europe PubMed DOI
    12. 2005
  12. [YEAR:14-3-2005]Forsyth,J.L., Beaudoin,F., Halford,N.G., Sessions,R.B., Clarke,A.R. and Shewry,P.R.
    Design, expression and characterisation of lysine-rich forms of the barley seed protein CI-2
    Biochim Biophys Acta1747, 221-227. PubMed  Europe PubMed DOI
  13. [YEAR:10-5-2005]Radisky,E.S., Lu,C.J., Kwan,G. and Koshland,D.E., Jr.
    Role of the intramolecular hydrogen bond network in the inhibitory power of chymotrypsin inhibitor 2
    Biochemistry44, 6823-6830. PubMed  Europe PubMed DOI
    14. 2004
  14. [YEAR:2-11-2004]Radisky,E.S., Kwan,G., Karen Lu,C.J. and Koshland,D.E., Jr.
    Binding, proteolytic, and crystallographic analyses of mutations at the protease-inhibitor interface of the subtilisin BPN'/chymotrypsin inhibitor 2 complex
    Biochemistry43, 13648-13656. PubMed  Europe PubMed DOI  S
    15. 2003
  15. [YEAR:13-2-2003]Lei,H.X. and Smith,P.E.
    The effects of internal water molecules on the structure and dynamics of chymotrypsin inhibitor 2
    J Phys Chem B107, 1395-1402. DOI
  16. [YEAR:3-6-2003]Radisky,E.S., King,D.S., Kwan,G. and Koshland,D.E., Jr.
    The role of the protein core in the inhibitory power of the classic serine protease inhibitor, chymotrypsin inhibitor 2
    Biochemistry42, 6484-6492. PubMed  Europe PubMed DOI
  17. [YEAR:19-8-2003]Villemure,M., Fournier,A., Gauthier,D., Rabah,N., Wilkes,B.C. and Lazure,C.
    Barley serine proteinase inhibitor 2-derived cyclic peptides as potent and selective inhibitors of convertases PC1/3 and furin
    Biochemistry42, 9659-9668. PubMed  Europe PubMed DOI
    18. 2001
  18. [YEAR:26-1-2001]Gordon-Smith,D.J., Carbajo,R.J., Stott,K. and Neuhaus,D.
    Solution studies of chymotrypsin inhibitor-2 glutamine insertion mutants show no interglutamine interactions
    Biochem Biophys Res Commun280, 855-860. PubMed  Europe PubMed DOI
  19. [YEAR:10-4-2001]Kazmirski,S.L., Wong,K.B., Freund,S.M., Tan,Y.J., Fersht,A.R. and Daggett,V.
    Protein folding from a highly disordered denatured state: the folding pathway of chymotrypsin inhibitor 2 at atomic resolution
    Proc Natl Acad Sci U S A98, 4349-4354. PubMed  Europe PubMed DOI
    20. 2000
  20. Roesler,K.R. and Rao,A.G.
    A single disulfide bond restores thermodynamic and proteolytic stability to an extensively mutated protein
    Protein Sci9, 1642-1650. PubMed  Europe PubMed DOI
    21. 1999
  21. [YEAR:16-2-1999]Chen,Y.W., Stott,K. and Perutz,M.F.
    Crystal structure of a dimeric chymotrypsin inhibitor 2 mutant containing an inserted glutamine repeat
    Proc Natl Acad Sci U S A96, 1257-1261. PubMed  Europe PubMed DOI  S
  22. Roesler,K.R. and Rao,A.G.
    Conformation and stability of barley chymotrypsin inhibitor-2 (CI-2) mutants containing multiple lysine substitutions
    Protein Eng12, 967-973. PubMed  Europe PubMed
    23. 1998
  23. [YEAR:19-5-1998]Hasan,Z. and Leatherbarrow,R.J.
    A study of the specificity of barley chymotrypsin inhibitor 2 by cysteine engineering of the P1 residue
    Biochim Biophys Acta1384, 325-334. PubMed  Europe PubMed DOI
    24. 1997
  24. [YEAR:1-11-1997]Chopin,V., Bilfinger,T.V., Stefano,G.B., Matias,I. and Salzet,M.
    Amino-acid-sequence determination and biological activity of cytin, a naturally occurring specific chymotrypsin inhibitor from the leech Theromyzon tessulatum
    Eur J Biochem249, 733-738. PubMed  Europe PubMed
    25. 1996
  25. Neira,J.L., Davis,B., Ladurner,A.G., Buckle,A.M., Gay,G. and Fersht,A.R.
    Towards the complete structural characterization of a protein folding pathway: the structures of the denatured, transition and native states for the association/folding of two complementary fragments of cleaved chymotrypsin inhibitor 2. Direct evidence for a nucleation-condensation mechanism
    Fold Des1, 189-208. PubMed  Europe PubMed  S
    26. 1995
  26. [YEAR:10-10-1995]Otzen,D.E., Rheinnecker,M. and Fersht,A.R.
    Structural factors contributing to the hydrophobic effect: the partly exposed hydrophobic minicore in chymotrypsin inhibitor 2
    Biochemistry34, 13051-13058. PubMed  Europe PubMed DOI
  27. [YEAR:21-2-1995]Shaw,G.L., Davis,B., Keeler,J. and Fersht,A.R.
    Backbone dynamics of chymotrypsin inhibitor 2: effect of breaking the active site bond and its implications for the mechanism of inhibition of serine proteases
    Biochemistry34, 2225-2233. PubMed  Europe PubMed
    28. 1994
  28. [YEAR:22-11-1994]Jackson,S.E. and Fersht,A.R.
    Contribution of residues in the reactive site loop of chymotrypsin inhibitor 2 to protein stability and activity
    Biochemistry33, 13880-13887. PubMed  Europe PubMed DOI
    29. 1993
  29. [YEAR:13-12-1993]Eder,J., Rheinnecker,M. and Fersht,A.R.
    Hydrolysis of small peptide substrates parallels binding of chymotrypsin inhibitor 2 for mutants of subtilisin BPN'
    FEBS Lett335, 349-352. PubMed  Europe PubMed DOI
  30. Jackson,S.E., Moracci,M., Elmasry,N., Johnson,C.M. and Fersht,A.R.
    Effect of cavity-creating mutations in the hydrophobic core of chymotrypsin inhibitor 2
    Biochemistry32, 11259-11269. PubMed  Europe PubMed  S
  31. [YEAR:5-12-1993]Krystek,S., Stouch,T. and Novotny,J.
    Affinity and specificity of serine endopeptidase-protein inhibitor interactions. Empirical free energy calculations based on X-ray crystallographic structures
    J Mol Biol234, 661-679. PubMed  Europe PubMed DOI
  32. [YEAR:19-10-1993]Osmark,P., Sorensen,P. and Poulsen,F.M.
    Context dependence of protein secondary structure formation: the three-dimensional structure and stability of a hybrid between chymotrypsin inhibitor 2 and helix E from subtilisin Carlsberg
    Biochemistry32, 11007-11014. PubMed  Europe PubMed DOI
    33. 1992
  33. Leatherbarrow,R.J. and Matthews,S.J.
    Carbon-13 nuclear magnetic resonance relaxation study of chymotrypsin inhibitor 2 (CI-2)
    Magn Reson Chem30, 1255-1260. DOI
    34. 1991
  34. Ludvigsen,S., Shen,H.Y., Kjaer,M., Madsen,J.C. and Poulsen,F.M.
    Refinement of the three-dimensional solution structure of barley serine proteinase inhibitor 2 and comparison with the structures in crystals
    J Mol Biol222, 621-635. PubMed  Europe PubMed  S
    35. 1990
  35. [YEAR:7-8-1990]Longstaff,C., Campbell,A.F. and Fersht,A.R.
    Recombinant chymotrypsin inhibitor 2: expression, kinetic analysis of inhibition with alpha-chymotrypsin and wild-type and mutant subtilisin BPN', and protein engineering to investigate inhibitory specificity and mechanism
    Biochemistry29, 7339-7347. PubMed  Europe PubMed DOI
    36. 1988
  36. McPhalen,C.A. and James,M.N.
    Structural comparison of two serine proteinase-protein inhibitor complexes: eglin-c-subtilisin Carlsberg and CI-2-subtilisin Novo
    Biochemistry27, 6582-6598. PubMed  Europe PubMed  S
    37. 1987
  37. McPhalen,C.A. and James,M.N.
    Crystal and molecular structure of the serine proteinase inhibitor CI-2 from barley seeds
    Biochemistry26, 261-269. PubMed  Europe PubMed  S
  38. [YEAR:15-5-1987]Williamson,M.S., Forde,J., Buxton,B. and Kreis,M.
    Nucleotide sequence of barley chymotrypsin inhibitor-2 (CI-2) and its expression in normal and high-lysine barley
    Eur J Biochem165, 99-106. PubMed  Europe PubMed
    39. 1976
  39. Yoshikawa,M., Iwasaki,T., Fujii,M. and Oogaki,M.
    Isolation and some properties of a subtilisin inhibitor from barley
    J Biochem79, 765-773. PubMed  Europe PubMed

feedback
Page created 8-September-2023

EMBL-EBI logo

© 2025 EBI
Terms of use